Literature DB >> 19120522

Japanese guideline for diagnosis and treatment of interstitial cystitis.

Yukio Homma1, Tomohiro Ueda, Takaaki Ito, Mineo Takei, Hikaru Tomoe.   

Abstract

Interstitial cystitis (IC) is a disease of the urinary bladder with lower urinary tract symptoms such as urinary frequency, bladder hypersensitivity and/or bladder pain and resultant serious impairment of quality of life. In Japan, assuming that IC is very rare, research activity and medical care of IC have been sparse until 2001, when the Society of Interstitial Cystitis of Japan (SICJ) and a patient support group were founded.(1,2) Subsequently the International Consultation on Interstitial Cystitis Japan (ICICJ) was held in Kyoto in 2003.(3) On the other hand, the etiology of IC has not been well clarified, which complicates its diagnosis and treatment at clinical settings. We have thus developed the Japanese Clinical Guideline,(4) which is targeted at healthcare professionals including specialists in urology and women's health care who may engage in the diagnosis and treatment of IC. This article is the English translation of a shortened version of the Guideline for convenience of readers worldwide.

Entities:  

Mesh:

Year:  2009        PMID: 19120522     DOI: 10.1111/j.1442-2042.2008.02208.x

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  11 in total

1.  The combination therapy of prednisolone and tacrolimus for severe painful bladder syndrome/interstitial cystitis.

Authors:  Gou Kaneko; Koshiro Nishimoto; Yujiro Ito; Atsushi Uchida
Journal:  Can Urol Assoc J       Date:  2012-04       Impact factor: 1.862

Review 2.  Bladder afferent hyperexcitability in bladder pain syndrome/interstitial cystitis.

Authors:  Naoki Yoshimura; Tomohiko Oguchi; Hitoshi Yokoyama; Yasuhito Funahashi; Satoru Yoshikawa; Yoshio Sugino; Naoki Kawamorita; Mahendra P Kashyap; Michael B Chancellor; Pradeep Tyagi; Teruyuki Ogawa
Journal:  Int J Urol       Date:  2014-04       Impact factor: 3.369

3.  Unexplained association between cystitis glandularis and interstitial cystitis in females: a retrospective study.

Authors:  Wei Zhang; You-sheng Yao; Ming-en Lin; Wei-jie Xie; Wen-wei Pan
Journal:  Int Urogynecol J       Date:  2015-08-01       Impact factor: 2.894

4.  The Challenges of Interstitial Cystitis: Current Status and Future Prospects.

Authors:  Samuel Belknap; Eric Blalock; Deborah Erickson
Journal:  Drugs       Date:  2015-12       Impact factor: 9.546

Review 5.  Grading of evidence for bladder pain syndrome: a comparative review of study quality assessment methods.

Authors:  S A Tirlapur; K S Khan
Journal:  Int Urogynecol J       Date:  2013-11-23       Impact factor: 2.894

Review 6.  An Overview of the Pathology and Emerging Treatment Approaches for Interstitial Cystitis/Bladder Pain Syndrome.

Authors:  Asad Ali; Nouman Safdar Ali; Muhammad Bilal Malik; Zohaib Sayyed; Malik Qistas Ahmad
Journal:  Cureus       Date:  2018-09-17

7.  Phase I study of KRP-116D, a 50% w/w dimethyl sulfoxide aqueous solution, on the systemic absorption from bladder by intravesical instillation in healthy Japanese subjects.

Authors:  Hideyo Shimada; Makoto Yono; Yuya Hojo; Yuka Hamamura; Atsushi Ootsuki
Journal:  Low Urin Tract Symptoms       Date:  2019-11-06       Impact factor: 1.592

8.  Current Understanding and Future Perspectives of Interstitial Cystitis/Bladder Pain Syndrome.

Authors:  Tomohiro Ueda; Philip M Hanno; Ryoichi Saito; Jane M Meijlink; Naoki Yoshimura
Journal:  Int Neurourol J       Date:  2021-06-30       Impact factor: 2.835

Review 9.  Role of cystoscopy and hydrodistention in the diagnosis of interstitial cystitis/bladder pain syndrome.

Authors:  Gisela Ens; Gustavo L Garrido
Journal:  Transl Androl Urol       Date:  2015-12

10.  Cystoscopic evaluation and clinical phenotyping in interstitial cystitis/bladder pain syndrome

Authors:  Ömer Acar; Tufan Tarcan
Journal:  J Turk Ger Gynecol Assoc       Date:  2018-11-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.